340 related articles for article (PubMed ID: 22801948)
1. B-cell depletion in the treatment of lupus nephritis.
Gregersen JW; Jayne DR
Nat Rev Nephrol; 2012 Sep; 8(9):505-14. PubMed ID: 22801948
[TBL] [Abstract][Full Text] [Related]
2. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
Harvey PR; Gordon C
BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
[TBL] [Abstract][Full Text] [Related]
3. B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.
Reddy V; Jayne D; Close D; Isenberg D
Arthritis Res Ther; 2013; 15 Suppl 1(Suppl 1):S2. PubMed ID: 23566295
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and lupus--a promising pair?
Ekö SL; van Vollenhoven RF
Curr Rheumatol Rep; 2014; 16(9):444. PubMed ID: 25074032
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.
Melander C; Sallée M; Trolliet P; Candon S; Belenfant X; Daugas E; Rémy P; Zarrouk V; Pillebout E; Jacquot C; Boffa JJ; Karras A; Masse V; Lesavre P; Elie C; Brocheriou I; Knebelmann B; Noël LH; Fakhouri F
Clin J Am Soc Nephrol; 2009 Mar; 4(3):579-87. PubMed ID: 19261822
[TBL] [Abstract][Full Text] [Related]
6. B cell depletion in lupus and Sjögren's syndrome: an update.
Coca A; Sanz I
Curr Opin Rheumatol; 2009 Sep; 21(5):483-8. PubMed ID: 19644378
[TBL] [Abstract][Full Text] [Related]
7. Inflammation: Rituximab in ANCA vasculitis and lupus: bittersweet results.
Bosch X
Nat Rev Nephrol; 2010 Mar; 6(3):137-9. PubMed ID: 20186231
[No Abstract] [Full Text] [Related]
8. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
9. Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies.
Leone A; Sciascia S; Kamal A; Khamashta M
Expert Rev Clin Immunol; 2015 Jan; 11(1):109-16. PubMed ID: 25511179
[TBL] [Abstract][Full Text] [Related]
10. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
[TBL] [Abstract][Full Text] [Related]
11. Improving B-cell depletion in systemic lupus erythematosus and rheumatoid arthritis.
Mota P; Reddy V; Isenberg D
Expert Rev Clin Immunol; 2017 Jul; 13(7):667-676. PubMed ID: 27841031
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in systemic lupus erythematosus and lupus nephritis.
Beckwith H; Lightstone L
Nephron Clin Pract; 2014; 128(3-4):250-4. PubMed ID: 25471633
[TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment in lupus nephritis--where do we stand?
Gunnarsson I; Jonsdottir T
Lupus; 2013 Apr; 22(4):381-9. PubMed ID: 23553781
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis: the evolving role of novel therapeutics.
Rovin BH; Parikh SV
Am J Kidney Dis; 2014 Apr; 63(4):677-90. PubMed ID: 24411715
[TBL] [Abstract][Full Text] [Related]
15. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome.
Coca A; Sanz I
Curr Opin Rheumatol; 2012 Sep; 24(5):451-6. PubMed ID: 22871954
[TBL] [Abstract][Full Text] [Related]
16. Minimising steroids in lupus nephritis--will B cell depletion pave the way?
Lightstone L
Lupus; 2013 Apr; 22(4):390-9. PubMed ID: 23553782
[TBL] [Abstract][Full Text] [Related]
17. B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases.
Sangle SR; Lutalo PM; Davies RJ; Khamashta MA; D'Cruz DP
J Autoimmun; 2013 Jun; 43():55-9. PubMed ID: 23608146
[TBL] [Abstract][Full Text] [Related]
18. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis.
Gomez Mendez LM; Cascino MD; Garg J; Katsumoto TR; Brakeman P; Dall'Era M; Looney RJ; Rovin B; Dragone L; Brunetta P
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1502-1509. PubMed ID: 30089664
[TBL] [Abstract][Full Text] [Related]
20. A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment.
Roccatello D; Sciascia S; Baldovino S; Rossi D; Alpa M; Naretto C; Di Simone D; Simoncini M; Menegatti E
Autoimmun Rev; 2015 Dec; 14(12):1123-30. PubMed ID: 26244817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
